← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 2, 1999First marketed drug
Aug 11, 1941First NDA
Aug 11, 1941Last known activity
Nov 2, 1999
Acquired by American Cyanamid → American Home Products → Pfizer on Jan 1, 1930
Timeline
1900s
- Jan 1, 1906
Lederle— Founded
1930s
- Jan 1, 1930
American Cyanamid— Acquired By
1940s
- Aug 11, 1941
sulfasalazine— NDA Secondary Org
2000s
- Oct 15, 2009
Pfizer— Now
Drugs by trial phase (10 distinct, 7 trials)
Phase 2 (2 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Approved for
- Acne Vulgaris
- Affective Disorders, Psychotic
- Altitude Sickness
- Anaplasmosis
- Anemia
- Anemia, Iron-Deficiency
- Anemia, Megaloblastic
- Bacterial Infections
- Bronchitis
- Bronchitis, Chronic
- Depressive Disorder
- Diabetes Mellitus, Type 2
- Filariasis
- Glaucoma
- Gonorrhea
- Hypertension
- Kidney Failure, Chronic
- Leptospirosis
- Loiasis
- Malaria
- Movement Disorders
- Osteoporosis
- Otitis Media
- Parkinson Disease
- Pharyngitis
- Pneumonia, Bacterial
- Pulmonary Eosinophilia
- Stomach Ulcer
- Tonsillitis
- Toxoplasmosis, Cerebral
- Typhoid Fever
- Urinary Tract Infections
Marketed drugs (56)
Recent trials (7)
- NCT00002002Lead sponsorN/ANov 2, 1999
- NCT00002254Lead sponsorN/ANov 2, 1999
- NCT00002003Lead sponsorPhase 2Nov 2, 1999
- NCT00000638CollaboratorN/ANov 2, 1999
- NCT00002260Lead sponsorN/ANov 2, 1999
- NCT00002271Lead sponsorN/ANov 2, 1999
- NCT00002259Lead sponsorPhase 2Nov 2, 1999
Details
- Founded
- New York, NY, US Jan 1, 1906
- First NDA
- Aug 11, 1941
- Last known activity
- Nov 2, 1999